AnalystsJames GordonJames Gordon's Stock Forecasts
AnalystsJames Gordon
Sectors:
Industries:
Analyst Ranking
Top 36%
#1812 out of 5069 analysts
Average Return
+31.42%
Win Rate
100%6 out of 6
Risk vs Reward
Poor
Good
James Gordon's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Argenx SeARGX | +56.03% | $359.48 | $560.90 | 2024-05-13 - 2025-05-12 | Strong Buy |
Argenx SeARGX | +43.32% | $588.67 | $843.66 | 2024-11-04 - 2025-10-17 | Strong Buy |
Argenx SeARGX | +35.99% | $459.57 | $624.96 | 2023-12-05 - 2024-12-04 | Strong Buy |
Argenx SeARGX | +27.74% | $516.69 | $660.00 | 2024-08-23 - 2025-08-22 | Strong Buy |
Argenx SeARGX | +22.21% | $690.32 | $843.66 | 2025-08-04 - 2025-10-17 | Strong Buy |
James Gordon Analyst Color
Get additional color on James Gordon's coverage of popular stocks
James Gordon's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Argenx SeARGX | 6 | Strong Buy | $830.00 | -1.62% | Maintains | 2 months ago |
Grifols SaGRFS | 1 | Hold | $10.30 | +6.74% | Maintains | 4 months ago |
Morphosys AgMOR | 1 | Hold | $24.00 | N/A | Downgrades | 4 years ago |
Fibrogen IncFGEN | 1 | Hold | N/A | N/A | Upgrades | 5 years ago |
Shire PLCSHPG | 1 | Hold | $150.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.